Andrew DaviesScientific Advisory Board Member

Andrew Davies, BSc, BM, FRCP, PhD, is Professor of Haematological Oncology in the Cancer Sciences Unit in the Faculty of Medicine, University Hospital Southampton, Southampton, UK. He completed his training in Medical Oncology at St Bartholomew’s Hospital, London, UK, and as a Cancer Research UK clinical fellow he undertook a PhD examining the molecular mechanisms underlying transformation of follicular lymphoma to more aggressive histological sub-types.

Professor Davies specialises in the treatment of malignant lymphoma and the use of high-dose chemotherapy. He has a particular interest in the investigation of monoclonal antibody-containing therapies applied to lymphoma and also in the translation of biomarkers and novel therapies to the clinical arena.  He has extensive experience in early phase trials, including leading several first-in-man lymphoma studies.

He is the past Chair of the UK National Cancer Research Institute High Grade Lymphoma Study Group and Director of Cancer Research UK/National Institute of Health Southampton Experimental Cancer Medicine Centre. He is also the Wessex Regional Lead for Cancers in Teenagers and Young Adults.

Positions of responsibility:

• Professor of Haematological Oncology
• Consultant in Medical Oncology
• Director of Southampton Experimental Cancer Medicine Centre
• Wessex Clinical Lead for Cancers in Teenagers and Young Adults